Edgar Filing: LUBRIZOL CORP

SCHEDULE 14A
(RULE 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11c or Section 240.14a-12

The Lubrizol Corporation
--------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)

--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

(1) Title of each class of securities to which transaction applies:

----------------------------------------------------------------------

(2) Aggregate number of securities to which transaction applies:

----------------------------------------------------------------------

(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):

----------------------------------------------------------------------

(4) Proposed maximum aggregate value of transaction:

----------------------------------------------------------------------

(5) Total fee paid:

----------------------------------------------------------------------

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:

----------------------------------------------------------------------

(2) Form, Schedule or Registration Statement No.:

----------------------------------------------------------------------

(3) Filing Party:

----------------------------------------------------------------------

(4) Date Filed:

----------------------------------------------------------------------

THE LUBRIZOL CORPORATION
29400 Lakeland Boulevard
Wickliffe, Ohio 44092

NOTICE OF ANNUAL MEETING

To Our Shareholders:

The 2004 Annual Meeting of Shareholders of The Lubrizol Corporation will be
held at the Radisson Hotel & Conference Center - Eastlake, 35000 Curtis
Boulevard, Eastlake, Ohio, on Monday, April 26, 2004, at 10:00 a.m. At the
meeting, we will ask you to:

1. Elect four directors for three-year terms;

2. Confirm the appointment of Deloitte & Touche LLP as independent
auditors; and

3. Transact other business that is properly presented at the meeting.

Shareholders of record at the close of business on March 5, 2004, may vote
at the meeting. The procedures for voting are described in the attached proxy
statement.

The business of the meeting and other information of interest to
shareholders is described in the attached proxy statement. After the meeting, we
will report on current operations and plans and have a question and answer
period.

At the 2003 meeting, approximately 78% of the shares were voted either in
person or by proxy. Your continued support is appreciated, and we hope that you
will be able to join us at the April 26 meeting.

L. M. Reynolds
Secretary

Wickliffe, Ohio
March 17, 2004

RETURN OF PROXIES REQUESTED

YOUR VOTE IS IMPORTANT. YOU CAN VOTE BY
TELEPHONE, OVER THE INTERNET OR BY
MAILING THE ENCLOSED PROXY CARD.

PROXY STATEMENT
--------------------------------------------------------------------------------

VOTING INFORMATION
--------------------------------------------------------------------------------

What may I vote on?

The Board of Directors asks for your vote on two proposals:

-- Election of nominees to serve on the Board of Directors; and

-- Confirmation of the appointment of Deloitte & Touche LLP as our
independent auditors.

Who can vote?

People who owned shares at the close of business on March 5, 2004, can vote
at the annual meeting. On March 5, 2004, there were 51,605,041 outstanding
shares of Lubrizol. Each share is entitled to one vote. This proxy statement and
the enclosed proxy card were first mailed to shareholders on or about March 17,
2004.

How do I vote?

You can vote any one of three ways:

-- By Telephone: Call the toll-free number (at no cost to you) on the
enclosed proxy card and follow the instructions. Telephone voting
is available 24 hours a day. Easy-to-follow voice prompts allow
you to vote your shares and confirm that your vote has been
properly recorded.

IF YOU VOTE BY TELEPHONE, YOU DO NOT NEED TO RETURN THE PROXY
CARD.

-- Over the Internet: Visit the Web site listed on the enclosed proxy
card and follow the instructions. Internet voting is available 24
hours a day. As with telephone voting, you will be given the
opportunity to confirm that your vote has been properly recorded.

IF YOU VOTE OVER THE INTERNET, YOU DO NOT NEED TO RETURN THE PROXY
CARD.

-- By Mail: Mark, sign, date and mail the enclosed proxy card to
American Stock Transfer & Trust Company in the enclosed
postage-paid envelope.

If you sign and return the proxy card or use the telephone or Internet
voting procedures, but do not indicate how you wish to vote, your shares will be
voted FOR the two proposals. If you indicate that you abstain, you will be
counted as present at the annual meeting for purposes of determining whether
there is a majority of outstanding shares at the meeting and you will be counted
as voting (but not for or against) that issue. Any broker nonvote also will be
counted as present at the annual meeting for purposes of determining whether
there is a majority of outstanding shares at the meeting but will not be counted
as voted.

We are not aware of any other business which will be presented at the
annual meeting. But, if there is other business that is properly presented at
the meeting, your signature on a proxy card or through the telephone or Internet
procedures gives authority to W.G. Bares, Chairman and Chief Executive Officer;
C.P. Cooley, Vice President and Chief Financial Officer; and L. M. Reynolds,
Corporate Secretary and Counsel, to vote on those matters in their best
judgment.

Please note: If you are a beneficial owner, please refer to the information
forwarded by your bank, broker or other holder of record to see which voting
options are available to you.

Can I revoke my vote?

You may revoke your proxy at any time before it is voted at the meeting by:

-- notifying Lubrizol's corporate secretary in writing;

-- voting at a later time by telephone or over the Internet;

-- returning a later-dated proxy card; or

-- voting in person at the annual meeting.

Your most recent vote will be the one used as your vote.

Who tabulates the vote?

American Stock Transfer & Trust Company serves as the independent tabulator
of votes and inspector of elections. It will report the voting results to us.
However, it will not identify to us how you voted on any issue unless:

-- there is a contested election for the Board of Directors;

-- it is required by law; or

-- you request it.

Who is paying for this proxy solicitation?

We are paying for the cost of soliciting your vote, including the cost of
mailing the proxy statement and proxy card as well as the costs of the telephone
and Internet voting procedures. We will, upon request, reimburse brokerage
houses, custodians, nominees and others for the out-of-pocket and reasonable
clerical expenses they incur in connection with this proxy solicitation.

How can I help Lubrizol save money by reducing the number of proxy materials
sent to my house?

We have adopted a procedure approved by the Securities and Exchange
Commission called "householding." Under this procedure we are saving money on
printing and mailing costs by sending only one proxy statement and annual report
to shareholders who have the same last name and address and do not participate
in electronic delivery of proxy materials (unless they have told us otherwise).
Shareholders who participate in householding will continue to receive separate
proxy cards. If you currently share the same last name and address with another
Lubrizol shareholder and in the future wish to have just one proxy statement and
annual report sent to your address, please contact our transfer agent at the
following address: American Stock Transfer & Trust Company, 59 Maiden Lane,
Plaza Level, New York, NY 10038, or by telephone at 1-800-627-2303.

If you participate in householding and you want to receive a separate copy
of the annual report or proxy statement either now or in the future, please
contact our transfer agent.

If you hold stock through a bank, broker or other holder of record, you can
contact them about receiving single or multiple copies of the proxy statements
and annual reports.

Instead of receiving a paper copy, can I access the proxy statement and the
annual report electronically?

The proxy statement and 2003 annual report are on our Internet site at
www.lubrizol.com/Investors/financial.asp.

You can elect to view future proxy statements and annual reports over the
Internet instead of receiving paper copies in the mail. You can choose this
option and save us the cost of producing and mailing these documents by
following the instructions provided on the enclosed proxy card. If you chose
this option, we will furnish you with instructions next year containing the
Internet address to access our proxy statement and annual report, but you will
not receive paper copies of either document.

If you hold stock through a bank, broker or other holder of record, check
the information provided by them for instructions on how to elect to view future
proxy statements and annual reports over the Internet. Most shareholders who
hold stock through a bank, broker or other holder of record and who elect
electronic access will receive an e-mail next year containing the Internet
address to access our proxy statement and annual report.

--------------------------------------------------------------------------------
ELECTION OF DIRECTORS
--------------------------------------------------------------------------------

The authorized number of Lubrizol directors is currently fixed at eleven,
divided into three classes. Two classes have four members each and one class has
three members. The directors in each class are elected for three-year terms so
that the term of office of one class of directors expires at each annual
meeting.

The Organization and Compensation Committee has recommended, and the Board
of Directors has approved, the nomination of the following four persons for
election as directors at this annual meeting:

-- James L. Hambrick

-- Gordon D. Harnett

-- Victoria F. Haynes

-- William P. Madar

Each of these persons is being nominated for a three-year term that will
end in 2006. Mr. Harnett, Dr. Haynes and Mr. Madar are currently Lubrizol
directors. If any of these persons becomes unavailable for election, your signed
proxy will be voted for the election of any person who is recommended by the
Organization and Compensation Committee or will be voted in favor of holding a
vacancy to be filled by the directors. The nominated persons who receive the
greatest number of votes will be elected to the open director positions.

The following information is presented for each person who is being
nominated for election as a director and for each other director who will
continue in office after the meeting:

NOMINEES FOR ELECTION

JAMES L. HAMBRICK, age 49, is President of The Lubrizol
Corporation. Mr. Hambrick joined Lubrizol as a co-operative
[JAMES L. HAMBRICK education student in 1973 and was hired full-time in 1978.
PHOTO] His career has encompassed a variety of responsible
positions in operations, marketing, technology and business
development. During the 1990's Mr. Hambrick led market
development activities in the former Soviet Union and in
China. He was elected Vice President of Asia-Pacific in
April 2000 and President in January 2003. He received a B.S.
degree in Chemical Engineering from Texas A&M University in
1978. He is a member of the American Institute of Chemical
Engineers.
GORDON D. HARNETT, age 61, is Chairman and Chief Executive
[GORDON D. HARNETT Officer of Brush Engineered Materials Inc., the world's
PHOTO] largest producer of beryllium and beryllium-containing
engineered products. Prior to joining Brush in 1991, Mr.
Harnett had been Senior Vice President of The BFGoodrich
Company. From 1977 to 1988, he had held a series of senior
executive positions with Tremco Inc., a wholly owned
subsidiary of BFGoodrich, including President and Chief
Executive Officer from 1982 to 1988. From 1969 through 1976,
Mr. Harnett worked for McKinsey & Co., including a two-year
assignment in Tokyo. Mr. Harnett became a Lubrizol director
in 1995. Mr. Harnett graduated from Miami University in 1964
with a B.S. degree in business administration. He received
an M.B.A. from Harvard University in 1969. Mr. Harnett is a
director of PolyOne Corporation and EnPro Industries, Inc.
In addition, he is a trustee of University Hospitals of
Cleveland, Cleveland Tomorrow and Greater Cleveland Growth
Association and is Chairman of Cleveland Development
Advisors, Inc. and the Greater Cleveland International Trade
Alliance.

VICTORIA F. HAYNES, age 56, is President of the Research
[VICTORIA F. HAYNES Triangle Institute, which provides government and industry
PHOTO] clients with research and development services in health,
pharmaceuticals, environmental protection, advanced tech-
nologies and public policy. Prior to joining Research
Triangle Institute in June 1999, Dr. Haynes was Vice
President-Research and Development and Chief Technical
Officer of The BFGoodrich Company, a specialty chemicals and
aerospace company. Dr. Haynes became a Lubrizol director in
1995. Dr. Haynes graduated from the University of California
at Berkeley in 1969 with a B.S. in chemistry. She received
an M.A. in college teaching in 1971 and a Ph.D. in
physical/organic chemistry in 1975 from Boston University
and followed with a post doctoral associate assignment at
Purdue University for two years. Dr. Haynes is a director of
Nucor Corporation, Ziptronix, Inc., Microelectronics Center
of North Carolina and PPG Industries. In addition, she is
active in the Council on Competitiveness.

WILLIAM P. MADAR, age 64, is Chairman of the Board of
[WILLIAM P. MADAR Nordson Corporation. He was Chief Executive Officer of
PHOTO] Nordson until he retired from that position in 1997. Nordson
Corporation manufactures and worldwide markets industrial
equipment, along with the software and application
technologies that enhance its use. He is also Chairman of
the Board of cPref, a developer of software for the market
research service industry. A 1961 graduate of Purdue
University with a B.S. degree in chemical engineering, he
earned an M.B.A. from Stanford University in 1965. Mr. Madar
became a Lubrizol director in 1992. He is a director of
Nordson Corporation and Brush Engineered Materials Inc. Mr.
Madar is a trustee of the Cleveland Museum of Art. He is
also co-chairman of the Advisory Committee for the Ohio
Innovation Fund, an early stage venture capital fund.

DIRECTORS WHOSE TERMS OF OFFICE WILL CONTINUE AFTER THE MEETING

W. G. BARES, age 62, is Chairman of the Board and Chief
[W. G. BARES PHOTO] Executive Officer of The Lubrizol Corporation. Mr. Bares
joined Lubrizol as a development engineer in 1963 and was
appointed Director of the Pilot Plant in 1972. He was
elected Vice President in 1978, Executive Vice President in
1980 and Chief Operating Officer in 1987 and became Chief
Executive Officer on January 1, 1996. He was elected
President in 1982 and served as President until January
2003. He was elected a director of Lubrizol in 1981 and
Chairman of the Board in 1996. A 1963 graduate of Purdue
University with a B.S. degree in chemical engineering, he
earned an M.B.A. from Case Western Reserve University in
1969. Mr. Bares is a member of the American Petroleum
Institute and the American Institute of Chemical Engineers,
having served as past chairman of its Cleveland section. In
addition, he is a director of Oglebay Norton Company,
KeyCorp and Applied Industrial Technologies and an Executive
Board Member of the Greater Western Reserve Council of the
Boy Scouts of America. Mr. Bares' term as a Lubrizol
director expires in 2005. Mr. Barnes has announced his
intention to retire as Chief Executive Officer effective
April 26, 2004, following the annual meeting. At that time,
the Board of Directors plans to elect James L. Hambrick
President and Chief Executive Officer. Mr. Bares will
continue as Chairman of the Board through year-end 2004 to
assist in the transition.

[JERALD A. BLUMBERG JERALD A. BLUMBERG, age 64, resigned in June 2000 as
PHOTO] President and Chief Executive Officer of Ambar, Inc., a
privately held oilfield services company. Prior to joining
Ambar, Inc. in January 1998, Mr. Blumberg held various
international and management positions during a 37-year
career with E. I. du Pont de Nemours & Company, Inc. From
October 1995 until his retirement on December 31, 1997, he
was an Executive Vice President, Chairman of DuPont Europe
and a member of the Office of the Chief Executive. Mr.
Blumberg became a Lubrizol director in 1999. Mr. Blumberg
received a B.S. in chemical engineering from Michigan
Technological University in 1960. He is a director of NOVA
Chemicals Corporation and a member of the National Society
of Professional Engineers and the American Institute of
Chemical Engineers. Mr. Blumberg's term as a Lubrizol
director expires in 2006.

[FOREST J. FARMER SR. FOREST J. FARMER, SR., age 63, is President and Chief
PHOTO] Executive Officer of The Farmer Group. He is also Chairman,
Chief Executive Officer and President of Enerflex Solutions
LLC, which provides value-added subassemblies to the
automotive industry and Trillium Teamologies, a technology
and engineering services company. Mr. Farmer was associated
with Chrysler Corporation from 1968 to 1994 where he held
various management positions including General Plants
Manager for Car and Truck Assembly Operations. From 1988
until 1994, he was President of Acustar, Inc., an automotive
components subsidiary of Chrysler Corporation. Mr. Farmer
became a Lubrizol director in 1997. Mr. Farmer graduated
from Purdue University in 1965 with a B.S. degree in biology
and physical education. He is a member of the Board of
Directors of Saturn Electronics and Engineering, Inc.,
American Axle & Manufacturing, St. John Health, the Macomb
Hospital Corporation and Friends of Scouting. Mr. Farmer's
term as a Lubrizol director expires in 2006.

DAVID H. HOAG, age 64, retired in 1999 as Chairman of The
[DAVID H. HOAG PHOTO] LTV Corporation, having retired in 1998 as Chief Executive
Officer of The LTV Corporation and as Chief Executive
Officer of LTV Steel Company. Mr. Hoag was appointed to the
position of Chairman in June 1991 after having been elected
President and Chief Executive Officer in January of that
year. Mr. Hoag became Executive Vice President of The LTV
Corporation in July 1986 and was concurrently named a member
of LTV's Board of Directors. Mr. Hoag became a Lubrizol
director in 1989. He is a native of Pittsburgh and attended
Allegheny College in Meadville, Pennsylvania, receiving a
Bachelor's Degree in 1960. He is a director of Brush
Engineered Materials Inc., The Chubb Corporation, PolyOne
Corporation and NACCO Industries, Inc. Mr. Hoag's term as a
Lubrizol director expires in 2005.

[PEGGY GORDON MILLER PEGGY GORDON MILLER, age 66, is President of South Dakota
PHOTO] State University. Prior to joining South Dakota State in
1998, Dr. Miller was Acting Vice President for Academic and
International Programs at the American Association of State
Colleges and Universities. She has also served as a Senior
Fellow at the National Center for Higher Education,
President of The University of Akron and Chancellor of
Indiana University Northwest. She became a Lubrizol director
in 1993. Dr. Miller is also a director of A. Schulman, Inc.
She is a member of the National Competitiveness Council, the
Governors Value Added Investment Board and chairs the
Nominating and the Global Priorities Commission for the
American Association of State Colleges and Universities. Dr.
Miller holds degrees from Transylvania University,
Northwestern University and Indiana University. Dr. Miller's
term as a Lubrizol director expires in 2005.

RONALD A. MITSCH, age 69, retired in 1998 as Vice Chairman
and Executive Vice President-Industrial and Consumer Markets
[RONALD A. MITSCH of 3M, a manufacturer of products for industrial,
PHOTO] commercial, health care and consumer markets. He began his
career with 3M in 1960 as a Senior Research Chemist. He
served various assignments in research and in 1979 was named
Managing Director, 3M Netherlands. He returned to the United
States in 1981 as Research and Development Vice President,
Life Sciences Sector. He was named Group Vice President,
Traffic and Personal Safety Products in 1985, Senior Vice
President, Research and Development in 1990, Executive Vice
President in 1991 and Vice Chairman in 1995. Dr. Mitsch
graduated from Hamline University in 1956 with a B.S. in
chemistry. He received an M.S. in organic chemistry in 1958
and a Ph.D. in organic chemistry in 1960 from the University
of Nebraska. Dr. Mitsch became a Lubrizol director in 1991.
He is a director of WTC Industries, GaMra Composites, Inc.
and Material Sciences Corporation where he is also non-
employee Chairman of the Board. In addition, he is the
Chairman for the Board of Trustees of Hamline University.
The Organization and Compensation Committee requested and
Dr. Mitsch agreed to continue in his term beyond the 2004
Annual Shareholders Meeting. Dr. Mitsch's term as a Lubrizol
director expires in 2006.

DANIEL E. SOMERS, age 56, is Vice Chairman of Blaylock &
Partners LP, a minority-owned investment banking group in
[DANIEL E. SOMERS New York. He retired in October 2001 as President and Chief
PHOTO] Executive Officer of AT&T Broadband, which provides local
and long distance service, high speed Internet access and
home entertainment service. Previously, Mr. Somers was
Senior Executive Vice President and Chief Financial Officer
of AT&T from May 1997 to December 1999. Prior to joining
AT&T, Mr. Somers was Chairman and Chief Executive Officer of
Bell Cablemedia, plc, of London for two years. From 1992 to
1995, he was Executive Vice President and Chief Financial
Officer of Bell Canada International, Inc. Prior to joining
Bell Canada, Mr. Somers held a number of senior executive,
financial and operating-management positions with Radio
Atlantic Holdings Ltd. and Imasco Ltd. Mr. Somers became a
Lubrizol director in 1999. Mr. Somers received a B.S. degree
in finance from Stonehill College in North Easton,
Massachusetts, in 1969. Mr. Somers is a director of The
Chubb Corporation and Boston Communications Group, Inc. and
he is Vice Chairman of the Board of Trustees of Stonehill
College. Mr. Somers' term as a Lubrizol director expires in
2006.

--------------------------------------------------------------------------------
DIRECTOR INDEPENDENCE
--------------------------------------------------------------------------------

In addition to the independence criteria under the New York Stock Exchange
listing standards, the Board adopted the following categorical standards to
determine director independence:

Former Employees. A director will not be considered independent if during
any of the past three years he or she has been an employee or whose immediate
family member has been an executive officer of Lubrizol or any of its
subsidiaries.

Former Auditors. A director will not be considered independent if during
any of the past three years he or she, or an immediate family member, has been
affiliated with or employed by our external auditors in the audit or tax
compliance functions.

Interlocking Directorates. A director will not be considered independent
if during any of the past three years he or she, or an immediate family member,
has been an executive officer of another company for which a Lubrizol executive
officer serves on the Board of Directors.

Immediate Family Members: Spouses, parents, children, siblings, mothers-
and fathers-in law, sons- and daughters-in-law, brothers- and sisters-in-law and
anyone who shares the director's home.

Attorneys, Investment Bankers, Consultants. A director will not be
considered independent if he or she is affiliated with a firm that is an
attorney, investment banker, consultant or similar advisor to Lubrizol.

Significant Customer or Supplier. A director will not be considered
independent if he or she is affiliated with or whose immediate family member is
an executive officer of a customer that represents more than the greater of $1
million or 2% of our total consolidated gross revenues. A director will not be
considered independent if he or she is affiliated with or whose immediate family
member is an executive officer of a supplier of which we represent more than the
greater of $1 million or 2% of its total consolidated gross revenues.

Significant Charitable Contribution Recipient. A director will not be
considered independent if he or she is employed as an executive officer of a
not-for-profit entity of which we represent more than the greater of $1 million
or 2% of its consolidated gross revenues.

The Board has determined that Jerald A. Blumberg, Forest J. Farmer, Sr.,
Gordon D. Harnett, Victoria F. Haynes, David H. Hoag, William P. Madar, Peggy
Gordon Miller, Ronald A. Mitsch and Daniel E. Somers meet these standards of
independence.

--------------------------------------------------------------------------------
LEAD OUTSIDE DIRECTOR
--------------------------------------------------------------------------------

Pursuant to the Board of Director Governance Guidelines, the Chair of the
Organization and Compensation Committee serves as the lead outside director, who
presides over executive sessions of the outside directors. You may communicate
with the outside directors of the Board through the lead outside director by
sending a letter marked "Confidential" and addressed to:

Lead Director, The Lubrizol Corporation Board of Directors
c/o Leslie M. Reynolds, Corporate Secretary,
The Lubrizol Corporation
29400 Lakeland Boulevard
Wickliffe, OH 44092

You may also send an email to the lead outside director through Lubrizol's
corporate secretary at lmre@lubrizol.com by indicating "Lead Director" in the
subject line. The corporate secretary will forward these emails to the lead
outside director.

--------------------------------------------------------------------------------
ANNUAL MEETING ATTENDANCE
--------------------------------------------------------------------------------

The Lubrizol Corporation Board of Directors Governance Guidelines provide
that the expectation for attendance at meetings is 100 percent, including the
Annual Meeting of Shareholders. Nine directors attended the Annual Meeting of
Shareholders on April 28, 2003.

--------------------------------------------------------------------------------
BOARD COMMITTEES
--------------------------------------------------------------------------------

The Board of Directors held ten meetings during 2003. The board has several
standing committees, including an Organization and Compensation Committee and an
Audit Committee. The Board of Directors has adopted written charters for each
committee.

ORGANIZATION AND COMPENSATION COMMITTEE

The Organization and Compensation Committee is made up of all the outside
directors and its responsibilities include corporate governance, director
nominations and executive compensation. The committee held eight meetings during
2003. Its principal functions are to:

-- Annually, review the written charter and corporate governance, and
perform a self-assessment.

-- Review and approve the proxy statement, including the Report of
the Organization and Compensation Committee on Executive
Compensation.

-- Determine criteria for selecting new directors and review and
recommend candidates for election as directors.

-- Review and recommend candidates for election as officers.

-- Oversee evaluation of the Board of Directors and management.

-- Evaluate the performance of the chief executive officer.

-- Set the compensation for the Board of Directors and the chief
executive officer

-- Review and approve officer compensation and executive employment
agreements.

-- Assure effective succession planning is conducted for the chief
executive officer and other executive officers.

-- Designate employees to receive grants of stock options and other
stock awards and determine the type and size of the awards.

-- Determine the size of the fund pools for the profit sharing plan,
year-end variable compensation plan and the performance pay plan.

-- Designate employees to receive awards under the performance pay
plan.

The committee identifies nominees for director through discussions with the
directors or other entities that may come in contact with qualified persons. If
desired, the committee will retain a search firm to identify nominees and will
approve the search firm fees to be paid by Lubrizol. This committee will
consider shareholder recommendations for director nominations. These
recommendations should be submitted in writing to Lubrizol's corporate secretary
by January 1 before the annual meeting.

The committee reviews and assesses the following criteria for all nominees
for directors, regardless of the source of the recommendation: independence,
diversity, age, judgment, skill, integrity, willingness to make the required
time commitment, the interplay of the candidate's experience with the experience
of other Board members and skills necessary to the needs of the Board at the
time of the opening.

The members of this committee are all of the outside directors. The Board
has determined that each of the members is independent under the rules of the
New York Stock Exchange and our independence criteria. The chair of this
committee serves as the lead outside director for purposes of chairing regularly
scheduled meetings of outside directors and for other responsibilities which the

outside directors designate. Gordon D. Harnett, chair of this committee,
currently is lead outside director.

AUDIT COMMITTEE

The principal functions of the Audit Committee are to:

-- Annually appoint the independent auditors and evaluate with
management the performance of the independent auditor. The
independent auditor is ultimately accountable to the Board and the
Audit Committee.

-- Review with the independent and internal auditors the planned
scope and results of audits and pre-approve all audit and
non-audit services performed by the independent auditor.

-- Hold conferences and reviews with the auditors regarding matters
that affect financial statements and the results of the
independent auditor's reviews, annual audit and report.

-- Review the adequacy and effectiveness of the internal audit
function.

-- Oversee Lubrizol's internal control structure.

-- Receive, retain and address complaints received by Lubrizol
regarding accounting, internal accounting controls or auditing
matters.

-- Provide oversight of the activities of the chief ethics officer
and review procedures for monitoring compliance with Lubrizol's
Ethical and Legal Conduct Guidelines.

-- Discuss risk assessment and risk management policies.

-- Annually review the written charter and perform a self-assessment.

-- Obtain advice and assistance from outside advisors, as desired.

-- Set clear hiring policies for employees or former employees of the
independent auditors.

-- Periodically report the activities of the committee to the Board.

In performing its functions, the Audit Committee acts in an oversight
capacity for Lubrizol's management processes and systems, internal control
structure, financial reporting and risk management. It is not responsible for
preparing or assuring the accuracy of Lubrizol's financial statements or
filings, or conducting audits of the financial statements.

The members of the Audit Committee are Daniel E. Somers (Chair), Victoria
F. Haynes, David H. Hoag, William P. Madar and Ronald A. Mitsch. None of the
members sits on more than three audit committees of public companies.

The Board of Directors has determined that Lubrizol has serving on the
Audit Committee at least one audit committee financial expert, as defined in
Item 401(h)(2) of Regulation S-K. Daniel E. Somers, Chair, is the audit
committee financial expert. The Board has determined that Mr. Somers and each of
the members of the Audit Committee is independent under the New York Stock
Exchange listing standards and our independence criteria.

AUDIT COMMITTEE REPORT

The Audit Committee reviews Lubrizol's financial reporting process on
behalf of the Board of Directors. The committee held five meetings during 2003.
During these meetings, the committee reviewed and discussed the audited
financial statements for 2003 separately with management and Lubrizol's
independent auditors, Deloitte & Touche LLP. The discussions with Deloitte &
Touche included matters required to be discussed by the Statement on Auditing
Standards No. 61. In addition, the committee received from Deloitte & Touche
written independence disclosures and the letter required by Independence
Standards Board Standard No. 1 and discussed with Deloitte &

Touche its independence. Based on the review of the audited financial statements
and the discussions described above, the committee recommended to the Board of
Directors that the audited financial statements be included in Lubrizol's Annual
Report on Form 10-K for the year ended December 31, 2003, for filing with the
Securities and Exchange Commission.

Daniel E. Somers, Chair William P. Madar
Victoria F. Haynes Ronald A. Mitsch
David H. Hoag

GOVERNANCE GUIDELINES AND COMMITTEE CHARTERS

The Lubrizol Corporation Board of Directors Governance Guidelines and all
the committee charters are located on our Internet site at
www.lubrizol.com/Investors/governance.

--------------------------------------------------------------------------------

DIRECTOR COMPENSATION
--------------------------------------------------------------------------------

Directors who are not Lubrizol employees receive a yearly cash retainer fee
of $16,000, plus $1,100 for each board meeting they attend and $1,100 for each
committee meeting they attend. If a committee meeting is held on a different day
from a board meeting, they receive $1,300 for the committee meeting.

Directors who are not Lubrizol employees may participate in a deferred
compensation plan for directors. Under this plan, directors may defer all or any
portion of their yearly fee and meeting attendance fees and have these amounts
credited to various cash investment accounts and/or a share unit account. The
investment returns of the cash investment accounts equal the performance of the
investment portfolios designated by the Organization and Compensation Committee.
The number of share units credited to the share unit account is based on the
price of Lubrizol shares on the day the share units are credited to the account
and includes additional share units credited for quarterly dividends paid on
Lubrizol shares. When a person is no longer a director, cash is distributed from
the person's cash account and Lubrizol shares are issued equal to the number of
share units in the person's share unit account.

Annually, each director who is not a Lubrizol employee automatically
receives an option to purchase 2,500 Lubrizol shares under the 1991 Stock
Incentive Plan.

Prior to 2004, directors who are not Lubrizol employees participated in a
deferred stock compensation plan. Under this plan, each nonemployee director
received 500 share units on each October 1, which are credited with additional
share units for quarterly dividends paid on Lubrizol shares. When a person is no
longer a director, Lubrizol shares are issued equal to the number of share units
in the person's account.

Starting in 2004, in lieu of the deferred stock compensation plan, each
nonemployee director will receive a cash amount equal to 500 times the closing
price of a Lubrizol share on October 1. The director may elect to defer any part
or all of this amount under the deferred compensation plan for directors.

--------------------------------------------------------------------------------

DIRECTOR SHARE OWNERSHIP GUIDELINES
--------------------------------------------------------------------------------

We have share ownership guidelines that require each nonemployee director
to own at least 5,200 Lubrizol shares. New directors have five years to reach
this target. All of the current nonemployee directors have met this target.

--------------------------------------------------------------------------------

SHARE OWNERSHIP OF DIRECTORS, EXECUTIVE OFFICERS
AND LARGE BENEFICIAL OWNERS
--------------------------------------------------------------------------------

The following table shows the number of shares beneficially owned on
January 31, 2004, by each director and each executive officer named in the table
below and by all executive officers and directors as a group. Each person has
sole voting and investment power for all the shares shown, unless otherwise
noted. Mr. Bares beneficially owns 2.0% of Lubrizol shares based on the total
shown in the table below. No other executive officer or director owns more than
1% of Lubrizol shares. All executive officers and directors as a group
beneficially own approximately 5.8% of Lubrizol shares.

Amount and Nature of Beneficial Ownership
------------------------------------------------------------------
Name of Direct Employee Exercisable Deferred
Beneficial Owner Total Ownership(1) Plan(2) Options(3) Share Units(4)
---------------- --------- ------------ -------- ----------- --------------

W. G. Bares................... 1,012,936 131,520 10,744 836,677 33,995
Jerald A. Blumberg............ 19,054 1,000 9,500 8,554
D. W. Bogus................... 77,134 1,980 3,493 61,875 9,786(5)
C. P. Cooley.................. 148,614 2,879 2,399 126,012 17,324
Forest J. Farmer, Sr. ........ 21,160 225 13,500 7,435
J. L. Hambrick................ 98,996 3,114 15,251 75,875 4,756
Gordon D. Harnett............. 32,445 200 15,500 16,745
Victoria F. Haynes............ 23,456 500 15,500 7,456
G. R. Hill.................... 361,990 45,807 3,359 305,139 7,685
David H. Hoag................. 32,047 4,149 19,500 8,398
S. F. Kirk.................... 200,404 18,381 1,969 166,836 13,218
William P. Madar.............. 39,433 2,295 17,500 19,638
Peggy Gordon Miller........... 26,658 1,100 19,500 6,058
Ronald A. Mitsch.............. 28,139 2,000 19,500 6,639
Daniel E. Somers.............. 16,853 1,469 9,500 5,884
All Executive Officers and
Directors as a Group........ 2,993,133 248,448 68,785 2,457,185 218,715

---------------
(1) This column includes shares owned by or jointly with family members,
including 300 of Mr. Bogus' shares, 114 of Mr. Hambrick's shares, 4,149 of
Mr. Hoag's shares, 18,381 of Mr. Kirk's shares and 23,578 of the shares held
by the group, for which they have shared voting and investment power.

(2) This column shows shares held in the profit sharing and savings plan, for
which the persons indicated have sole voting power and limited investment
power.

(3) This column shows shares covered by stock options that are currently
exercisable or will be exercisable by March 31, 2004.

(4) This column shows the indirect share ownership held by directors and
officers under various deferred compensation plans described in this proxy
statement. Some share units attributable to deferrals on or after January 1,
2004, will be paid solely in cash.

(5) This number includes 2,159 share units under a supplemental retirement plan.
Share units attributable to additions to the plan on or after January 1,
2004, will be paid solely in cash.

SHARE OWNERSHIP GUIDELINES

We have share ownership guidelines that require executive officers to hold
shares having a value between 1.5 and 4 times their fixed pay, depending on
their position.

FIVE PERCENT BENEFICIAL OWNERS

The following table lists each person we know to be an owner of more than
5% of our shares on December 31, 2003.

Amount and Nature
of Beneficial Percent
Name and Address of Beneficial Owner Ownership of Class
------------------------------------ ----------------- --------

Alliance Capital Management L.P............................. 5,978,072(1) 11.6%
1290 Avenue of the Americas
New York, New York 10104
Mac-Per-Wolf Company........................................ 3,062,200(2) 5.9%(2)
310 S. Michigan Ave., Suite 2600
Chicago, IL 60604
State Street Bank and Trust Company......................... 2,653,260(3) 5.14%(3)
255 Franklin Street
Boston, MA 02110
Dodge & Cox................................................. 2,584,121(4) 5.0%(4)
One Sansome St., 35th Floor
San Francisco, CA 94104

---------------
(1) This information was obtained from a Schedule 13G dated February 13, 2004,
filed by Alliance Capital Management L.P., which is an investment adviser
registered under the Investment Advisers Act of 1940. Alliance Capital
Management L.P. reported sole voting power as to 2,815,672 shares, shared
voting power as to 829,346 shares, sole investment power as to 5,962,672
shares and shared investment power as to 15,400 shares. Alliance Capital
Management L.P. also serves as an investment advisor for Lubrizol's pension
and profit sharing plans. However, under investment guidelines applicable to
Lubrizol's pension and profit sharing plans, investment advisors are not
permitted to invest our plans' assets in Lubrizol shares. Lubrizol paid
Alliance Capital Management L.P. approximately $259,000 for investment
advisory services rendered during 2003.

(2) This information was obtained from a Schedule 13G dated January 30, 2004,
filed by Mac-Per-Wolf Company, which is an investment adviser registered
under the Investment Advisers Act of 1940. Mac-Per-Wolf Company reported
sole voting power as to 3,062,200 shares, shared voting power as to zero
shares, sole investment power as to 3,062,200 shares and shared investment
power as to zero shares.

(3) This information was obtained from a Schedule 13G dated February 6, 2004,
filed by State Street Bank and Trust Company. All shares were held in a
fiduciary capacity. State Street Bank and Trust Company reported sole voting
power as to 883,249 shares, shared voting power as to 1,748,014 shares, sole
investment power as to 901,716 shares and shared investment power as to
1,751,544 shares. State Street Bank and Trust Company serves as trustee of
Lubrizol's profit sharing and 401(k) savings plan. Lubrizol paid State
Street Bank and Trust Company $6,666.66 for trustee services during 2003.

(4) This information was obtained from a Schedule 13G dated February 17, 2004,
filed by Dodge & Cox, which is an investment adviser registered under the
Investment Advisers Act of 1940. Dodge & Cox reported sole voting power as
to 2,356,371 shares, shared voting power as to 20,000 shares, sole
investment power as to 2,584,121 shares and shared investment power as to
zero shares.

--------------------------------------------------------------------------------

EXECUTIVE COMPENSATION
--------------------------------------------------------------------------------

The following table shows the compensation for 2003, 2002 and 2001 of the
chief executive officer and the next five highest-paid executive officers.

SUMMARY COMPENSATION TABLE

Long-Term Compensation
-------------------------------------
Awards Payouts
Annual Compensation ------------------------- ---------
---------------------------------- Securities
Other Restricted Underlying Long-term
Name and Annual Stock Options/ Incentive All Other
Principal Position Year Salary Bonus Compensation Awards SARs(No.)(2) Payouts Compensation(3)
------------------ ---- -------- -------- ------------ ---------- ------------ --------- ---------------

W. G. Bares
Chairman of the Board
and Chief Executive
Officer.................... 2003 $852,054 $505,000 $ 8,053 0 0 N/A $744,082
2002 823,789 900,000 9,640 0 159,995 N/A 39,487
2001 802,581 304,000 10,113 0 245,934 N/A 39,943
J. L. Hambrick
President.................. 2003 $373,208 215,000 90,549 0 0 N/A 73,065
2002 193,076 146,000 4,777 0 16,500 N/A 10,041
2001 175,611 45,000 9,468 0 33,000 N/A 7,818
G. R. Hill
Senior Vice President...... 2003 385,742 160,000 2,524 0 0 N/A 245,319
2002 373,207 265,000 3,054 0 40,000 N/A 23,771
2001 362,563 98,000 3,625 0 80,000 N/A 23,014
C. P. Cooley
Vice President and Chief
Financial Officer.......... 2003 315,355 131,000 3,514 $457,500(4) 0 N/A 104,619
2002 298,075 215,000 3,365 0 29,036 N/A 13,813
2001 290,208 80,000 3,229 0 54,000 N/A 11,108
D. W. Bogus
Vice President............. 2003 279,921 135,000 3,163 457,500(4) 0 N/A 118,860(5)
2002 267,226 203,000 2,577 0 16,500 N/A 27,060(5)
2001 244,188 68,000 2,683 0 33,000 N/A 25,118(5)
S. F. Kirk
Vice President............. 2003 290,390 124,000 3,745 457,500(4) 0 N/A 148,879
2002 277,281 203,000 3,365 0 33,672 N/A 13,027
2001 269,107 82,000 3,229 0 60,679 N/A 11,761

---------------
(1) This column reflects the payment of taxes by us on behalf of the officer
relating to the use of financial planning services. For Mr. Bares in 2003,
it also includes the payment of taxes by us relating to his use of company
transportation. For Mr. Hambrick in 2003, it also includes $66,711 for
business club initiation fees.

(2) This column reflects the number of shares covered by stock options granted
during the year.

(3) This column reflects our contributions to the profit sharing and savings
plan for these executives, including accruals to the related supplemental
defined contribution plan and amounts expensed under the executive death
benefit program, described on page 21. These amounts have not been received
by these executives. This column also reflects the dollar value of shares
that became distributable on March 24, 2003 under the 1991 Stock Incentive
Plan pursuant to the performance share stock award program. The number and
market value of shares distributable on March 24, 2003 for each of the named
executive officers is as follows: Mr. Bares, 23,500, $705,000; Mr. Hambrick,
1,500, $45,000; Dr. Hill, 7,500, $225,000; Mr. Cooley, 3,000, $90,000; Mr.
Bogus, 3,000, $90,000; and Mr. Kirk, 4,500, $135,000.

(4) The Organization and Compensation Committee granted 15,000 restricted shares
to each of Mr. Cooley, Mr. Kirk and Mr. Bogus, as part of executive
employment agreements. The shares

will be issued only if the executive is still an employee on January 1,
2008. The dollar value of the restricted shares on December 31, 2003 was
$487,800. Dividends are not paid on the restricted shares.

(5) This amount includes the grant date value of share units credited to a
supplemental retirement account described on page 21. These amounts have not
been received by this executive.

STOCK INCENTIVE PLANS

Our 1991 Stock Incentive Plan allows grants of incentive and nonstatutory
stock options, as well as stock appreciation rights and restricted and
nonrestricted stock awards. Any of our employees and our subsidiaries' employees
may be selected to participate in the plan. The plan is administered by the
Organization and Compensation Committee, which selects participants and
determines the type and amount of awards granted.

The number of shares available under the plan during a calendar year is 1%
of the outstanding shares on January 1 of that year, plus any unused shares from
previous years. The option price for stock options is not less than the average
of the high and the low market prices of shares on the grant date. The term of
each option is fixed by the committee. Participants can exercise their options
50% after one year, 75% after two years and 100% after three years. All
outstanding options become fully exercisable upon a change of control.

Under this plan, any person who pays the option price of options granted
prior to March 27, 2000, under the plan with shares already owned will
automatically receive a new option grant for the number of shares used to pay
the option price. These option grants are called reload options. For options
granted on or after March 27, 2000, the committee in its discretion may grant a
reload option for the number of shares used to pay the option price. Persons may
not transfer shares acquired from the exercise of a reload option while still an
employee or director unless they have met any applicable share ownership
guidelines. We eliminated reloads for new options granted on or November 11,
2002.

We also have options outstanding under our 1985 Employee Stock Option Plan.
However, no new options are granted under this plan.

The following tables show option transactions for the named executive
officers during 2003. No options were granted to the named executive officers
during 2003. No stock appreciation rights were granted, exercised or outstanding
in 2003.

AGGREGATED OPTION EXERCISES IN 2003 AND DECEMBER 31, 2003, OPTION VALUES

Number of Securities
Underlying Value of Unexercised
Shares Unexercised Options In-the-Money Options
Acquired at December 31, 2003 at December 31, 2003(2)
on Value --------------------------- ---------------------------
Name Exercise Realized(1) Exercisable Unexercisable Exercisable Unexercisable
---- -------- ----------- ----------- ------------- ----------- -------------

W. G. Bares.......... 0 $ 0 750,427 115,000 $1,588,239 $ 127,650
J. L. Hambrick....... 0 0 63,500 16,500 189,155 18,315
G. R. Hill........... 18,000 7,425 275,139 40,000 672,927 44,400
C. P. Cooley......... 0 0 105,762 27,000 327,916 29,970
D. W. Bogus.......... 0 0 49,500 16,500 123,379 18,315
S. F. Kirk........... 11,534 76,835 146,586 27,000 254,859 29,970

---------------

(1) The amounts in this column are the differences between the fair market value
at the exercise date of the Lubrizol shares acquired through the option
exercises and the exercise price of the option.

(2) The amounts in these columns are the differences between the fair market
value of Lubrizol shares at December 31, 2003 ($32.585 per share), and the
exercise price of the option. An option is considered in-the-money when the
fair market value of the shares is greater than the exercise price of the
option.

LONG-TERM INCENTIVE PLAN

LONG-TERM INCENTIVE PLAN -- AWARDS IN 2003(1)

Performance or Estimated Future Payouts Under
Number of Other Period Non-Stock Price-Based Plans
Shares, Units until ------------------------------------------------
or Other Maturation or Threshold Target Maximum
Name Rights Payout Dollars/Shares Dollars/Shares Dollars/Shares
---- ------------- -------------- -------------- -------------- --------------

W. G. Bares............ (1) (2) $1,044,588 $2,089,176 $6,267,529
14,616 29,232 87,695
J. L. Hambrick......... (1) (2) $ 239,261 $ 478,522 $1,435,565
3,348 6,695 20,086
G. R. Hill............. (1) (2) $ 217,791 $ 435,583 $1,306,748
3,047 6,095 18,284
C. P. Cooley........... (1) (2) $ 176,678 $ 353,357 $1,060,070
2,472 4,944 14,832
D. W. Bogus............ (1) (2) $ 147,612 $ 295,224 $ 885,673
2,065 4,131 12,392
S. F. Kirk............. (1) (2) $ 153,152 $ 306,304 $ 918,912
2,143 4,286 12,857

---------------

(1) Dollar-based target awards are determined by the Organization and
Compensation Committee in the December prior to the three-year performance
period. A portion of the award is converted into a number of share units
based on the price of Lubrizol stock on the date of the award. There are no
voting or dividend rights associated with the share units until the end of
the performance period and payouts, if any, are made in shares. Target
awards correspond to a pre-determined three-year earnings per share growth
rate target. The three-year earnings per share growth rate must reach a
minimum pre-determined threshold before any payout would be made. The
maximum payout corresponds to a three-year earnings per share growth rate
that is more than twice the target growth rate. If targets are met the
Organization and Compensation Committee has the sole discretion to pay the
share units in shares, but only if a shareholder approved vehicle is
available from which to issue shares. Otherwise, share units will be paid in
cash based on the price of Lubrizol stock on the date the award is payable.

(2) The performance period runs from 2004 through 2006. Payouts, if any, will be
made in 2007.

REPORT OF THE ORGANIZATION AND COMPENSATION COMMITTEE ON EXECUTIVE COMPENSATION

The Organization and Compensation Committee approves the compensation
packages for executive officers. The committee consists of all the outside
directors.

Factors Considered by the Committee

In carrying out its responsibilities in 2003, the committee considered the
following:

-- Advice from independent consultants on all aspects of Lubrizol's
compensation policies, including comparisons to the policies and
practices of other companies;

-- Relevant trends in executive compensation practices;

-- Lubrizol's financial performance;

-- Lubrizol's business performance;

-- Lubrizol's compensation policies and practices for employees
generally;

-- Recommendations of executive management on compensation of key
employees including executive officers; and

-- The committee's and Lubrizol's historical philosophy to reward
according to Lubrizol's performance and according to individual
contribution, including the individual's commitment to Lubrizol.

Cash Compensation of Employees Generally

The cash compensation of most employees, including the executive officers
named in the compensation table in this proxy statement, consists of (1) base
salary, (2) quarterly pay and (3) variable pay.

Quarterly pay is a fixed percentage of base salary determined by an
employee's length of service. Employee base salary plus quarterly pay is
designed to be within the mid-level range of salaries for persons having similar
jobs in the chemical and related industries.

Variable pay authorized by the committee for employees, other than
executive officers and other key employees, is paid in the first quarter and is
based upon a percentage of the previous year's net income. Variable pay is
allocated to employees based on a uniform percentage of each employee's base
salary.

Cash Compensation of Executive Officers

The base salary and quarterly pay practices for employees also apply to
executive officers.

For executive officers, five separate surveys selected by the committee's
compensation consultant are used to determine base salary plus quarterly pay.
These surveys include more companies than the published industry
line-of-business indices used to compare total shareholder return on page 18 of
this proxy statement; however, nine peer chemical companies are included in both
the salary surveys and the published industry indices. In addition, for the six
highest paid executives, total compensation levels and practices are analyzed
using compensation data published in each peer organization's proxy statement.
This analysis considers fixed salary, annual incentive, total cash compensation,
long-term incentives and total compensation.

The committee also reviews Lubrizol's three-year performance compared to a
peer group of 16 companies by analyzing total shareholder return, economic value
added, return on equity, return on assets and growth in earnings per share. This
analysis helps ensure that total executive pay is in alignment with Lubrizol's
performance relative to its peer group.

The committee administers the executive compensation policy with the
objective of keeping executive compensation comparable with other companies in
the chemical and related industries. The average executive base salary plus
quarterly pay in 2003 was slightly above the mid-level range when compared to
fixed compensation paid by companies in the surveys.

Executive officers and other key employees can receive variable cash
compensation under a performance pay plan. The committee determines a percentage
of annual net income to establish the amount available under this plan. For
2003, this percentage was based on objective financial measures and objective
and subjective performance measures for initiatives relating to our strategies
for (1) running the business and (2) changing the business. The objective
financial measures include earnings per share and contribution income from the
fluid technologies for industry segment.

Sixty percent of the weighting for all the performance measures is based
upon financial measures with the largest portion weighted to earnings per share.
The payout under the performance pay plan will vary based upon goal
accomplishment. Even if other goals are reached, earnings per share must reach a
minimum predetermined threshold before the plan will make payments.

The committee has the discretion to adjust the amount available under the
performance pay plan and to determine individual payouts under the performance
pay plan based upon an executive's

level of responsibility, recommendations by executive management and a
subjective judgment by the committee of the executive's contribution to
Lubrizol's financial and business performance.

Long-term Incentive Compensation

Performance Share Stock Awards

The committee granted performance share stock awards to executive officers
in 1997. Newly elected executive officers received proportional performance
share stock awards at the time of hire or promotion. These performance share
stock awards were to vest if the closing market price of Lubrizol shares reached
$45 for ten consecutive trading days. Otherwise, these awards were to vest on
March 24, 2003. On March 24, 2003, the performance share stock awards vested and
60,750 shares became distributable.

Long-term Incentive Plan

In 2002, the committee approved a long-term performance incentive program
that will provide to certain executive officers a target payout of cash and
shares in 2006 if a three-year earnings per share growth target is met. The
2003-2005 earnings per share growth target was set by the committee prior to the
beginning of 2003. The payout percentage will vary up or down based upon the
actual three-year earnings per share growth. The three-year earnings per share
growth must reach a minimum threshold of the pre-determined target or no
long-term incentive benefits will be paid.

In December 2003, the committee approved a three-year earnings per share
growth target for the three-year period of 2004-2006. If the three-year earnings
per share growth reaches a minimum threshold of the pre-determined target, cash
and, at the discretion of the committee shares will be paid if a shareholder
approved equity plan exists in 2007.

Deductibility of Executive Compensation

Section 162(m) of the Internal Revenue Code of 1986 limits the
deductibility of compensation paid to specified executive officers of public
companies. All compensation paid for 2003 to Lubrizol executive officers,
including the compensation element of shares received under Lubrizol's stock
equity plans, qualified for deduction.

Compensation of the Chief Executive Officer

The committee's intent is to set Mr. Bares' base salary plus quarterly pay
within a range that is competitive with the fixed salaries of chief executive
officers in the chemical and related industries. Mr. Bares did not receive a
salary increase during 2003. Mr. Bares' base salary and quarterly pay is below
to the mid-level range of comparable salaries.

Mr. Bares received 37% of his total cash compensation for 2003 from the
performance pay plan. For 2003, earnings per share exceeded the 2003 minimum
threshold.

In setting Mr. Bares' total compensation, the committee considers various
other aspects of corporate performance including market position, productivity,
product leadership, personnel development, employee attitudes, public
responsibility, quality and safety practices and the balancing of short-term and
long-term goals. For 2003, Mr. Bares' total compensation was at the mid-level
range of comparable total compensation of chief executive officers of peer
chemical companies.

In determining Mr. Bares' target long-term incentive opportunity for the
2003-2005 three-year period under the long-term incentive program described
above, the committee considered data provided by independent consultants and
relevant trends in executive compensation practices. The payout, if any, to Mr.
Bares under this program will depend on the actual earnings per share growth for
the three-year period. The three-year earnings per share growth must reach a
minimum threshold of the pre-determined earnings per share growth target or no
long-term incentive benefits will be paid.

Lubrizol's share ownership guidelines require Mr. Bares to hold shares
valued at four times his annual fixed pay. At year end, he owned over six times
his annual fixed pay in shares.

Gordon D. Harnett, Chair William P. Madar
Jerald A. Blumberg Peggy Gordon Miller
Forest J. Farmer, Sr. Ronald A. Mitsch
Victoria F. Haynes Daniel E. Somers
David H. Hoag

PERFORMANCE COMPARISONS

The following chart compares our combined total shareholder returns for the
five years ended December 31, 2003, to the combined total shareholder returns of
the Standard & Poor's 500 Index and the Standard & Poor's Chemical Group Index.
We have replaced the Standard & Poor's Industrial Index with the Standard &
Poor's 500 Index, and replaced the Standard & Poor's Specialty Chemicals Index
and the Dow Jones Chemical Index with the Standard & Poor's Chemical Group
Index.

[PERFORMANCE COMPARISONS CHART]

-----------------------------------------------------------------------------------------
12/98 12/99 12/00 12/01 12/02 12/03
-----------------------------------------------------------------------------------------

The Lubrizol Corporation 100.00 124.95 108.82 153.33 137.64 151.76
-----------------------------------------------------------------------------------------
S&P 500 100.00 121.04 110.02 96.95 75.52 97.18
-----------------------------------------------------------------------------------------
S&P Chemical Group 100.00 123.15 104.37 104.35 101.68 128.66
-----------------------------------------------------------------------------------------

We have selected the Standard & Poor's 500 Index because we believe it
provides a broad equity market comparison, and is widely used for comparison by
our peer group. We have reduced our number of chemical industry indices from two
to one to simplify our performance comparison, and have selected the Standard &
Poor's Chemical Group Index because we believe this index is a better
representation of chemical and specialty chemical producers. We believe we have
a peer group relationship with companies in the Standard & Poor's Chemical Group
Index.

No single peer index or peer company is totally comparable to our business.
Included in the Standard & Poor's Chemical Group Index are companies which
supply specialty chemicals and other related products to a wide variety of
markets. Some of our direct competitors are chemical divisions that represent
small portions of large oil companies. These chemical divisions are not included
in the peer comparison because information is not available to us which shows
those divisions separately from the parent company.

The following chart compares our combined total shareholder returns for the
five years ended December 31, 2003, to the combined shareholder returns for the
Standard & Poor's 500 Index and the Standard & Poor's Chemical Group Index
(newly selected indices), as presented previously, along with the Standard &
Poor's Industrial Index, the Standard & Poor's Specialty Chemicals Index, and
the Dow Jones Chemical Index. The comparison provides both the newly selected
indices and the indices used in the immediately preceding fiscal year.

[PERFORMANCE COMPARISONS CHART]

The Lubrizol Corporation.......... 100.00 124.95 108.82 153.33 137.64 151.76
-----------------------------------------------------------------------------------------
S & P Industrials................. 100.00 121.50 128.64 121.26 89.31 118.07
-----------------------------------------------------------------------------------------
S & P Specialty Chemicals......... 100.00 113.03 94.17 100.69 113.37 135.16
-----------------------------------------------------------------------------------------
Dow Jones US Chemicals............ 100.00 122.57 106.60 106.29 102.78 127.22
-----------------------------------------------------------------------------------------
S & P 500......................... 100.00 121.04 110.02 96.95 75.52 97.18
-----------------------------------------------------------------------------------------
S & P Chemicals Group............. 100.00 123.15 104.37 104.35 101.68 128.66
-----------------------------------------------------------------------------------------

The above charts assume the investment of $100 on December 31, 1998, and
the immediate investment of all dividends.

--------------------------------------------------------------------------------

EMPLOYEE AND EXECUTIVE OFFICER BENEFIT PLANS
--------------------------------------------------------------------------------

In addition to the stock option and variable compensation plans described
in this proxy statement and the group health, life and disability insurance
plans available to all employees, we also have the following plans for employees
and executive officers.

PENSION PLANS

We have a qualified pension plan for all employees. We also have a basic
supplemental defined benefit plan which provides highly paid employees with the
portion of their retirement benefits not payable from the pension plan because
of tax law limitations. In addition, we have a special officers' supplemental
defined benefit plan which covered two officers as of December 31, 2003, and is
described in the paragraph below the pension table.

Benefits under the pension plan and the related basic supplemental plan are
based on a final average pay formula or a career average pay formula, whichever
produces the higher benefit to the employee. The table below uses the final
average pay formula because it produces the higher benefit at the pay levels
shown.

Final average pay is an average of an employee's highest five consecutive
years out of the last ten years of pay. Pay for the plans consists of base
salary (unreduced for elective before-tax savings contributions and before-tax
cafeteria plan contributions), quarterly pay, overtime pay, shift premium
differentials, vacation and holiday pay, paid variable compensation, long-term
disability benefits and (for purposes of the basic and special supplemental
plans) cash compensation deferrals. Pay used to determine benefits for each of
the named executive officers is equal to the amounts shown in the salary and
bonus columns for them in the summary compensation table in this proxy
statement.

Benefits are based on a 10-year certain and life annuity. Employees hired
before February 1, 1984, may elect a lump sum option. Other payment options
available to all employees are a joint and 100% or 50% survivor annuity.

The final average pay formula limits years of service to 30. The estimated
credited years of service for each of the named executive officers (after this
30-year service limitation) is as follows: Mr. Bares, 30 years; Mr. Kirk, 30
years; Mr. Hambrick, 25 years; Dr. Hill, 21 years; Mr. Cooley, 6 years; and Mr.
Bogus, 4 years.

The following table shows the estimated annual retirement benefits payable
at age 65 under the pension plan and the basic supplemental defined benefit plan
in the final average pay and years of service categories shown. The benefits are
shown as a 10-year certain and life annuity.

Final Credited Years of Service
Average --------------------------------------------------------------------
Pay 10 Years 15 Years 20 Years 25 Years 30 Years 35 Years
---------- -------- -------- -------- -------- -------- --------

$ 200,000 ................ 27,140 40,710 54,280 67,850 81,420 81,420
400,000 ................ 56,140 84,210 112,280 140,350 168,420 168,420
600,000 ................ 85,140 127,710 170,280 212,850 255,420 255,420
800,000 ................ 114,140 171,210 228,280 285,350 342,420 342,420
1,000,000 ................ 143,140 214,710 286,280 357,850 429,420 429,420
1,200,000 ................ 172,140 258,210 344,280 430,350 516,420 516,420
1,400,000 ................ 201,140 301,710 402,280 502,850 603,420 603,420
1,600,000 ................ 230,140 345,210 460,280 575,350 690,420 690,420

As of December 31, 2003, Mr. Bares, Mr. Hambrick and Dr. Hill were
participants in the special officers' supplemental defined benefit plan.
Benefits under this plan are based on an average of the highest three
consecutive years of pay during the last ten years. The plan limits years of
service to 30 and computes benefits on the basis of a 10-year certain and life
annuity. Benefits are reduced for Social Security and payments made under other
Lubrizol benefit plans. After making all the deductions required under the plan,
the estimated additional annual benefit payable under this plan at age 65
(assuming current final average pay) to Mr. Bares is $1.6 million, to Mr.
Hambrick is $19,000 and to Dr. Hill is $8,000.

PROFIT SHARING AND SAVINGS PLAN

We have a qualified profit sharing and savings plan for all employees. Each
year, the Board of Directors determines the portion of Lubrizol profits that
will be contributed to the plan. Profit sharing contributions are allocated to
employees' accounts based on their pay.

In addition, employees may contribute up to 18% (16% for highly compensated
employees) of base plus quarterly pay to the plan as a before-tax contribution.
Lubrizol matches 50% of the employee's before-tax contributions up to 4% of the
employee's base plus quarterly pay. Employees also may make after-tax
contributions subject to an overall limit of 18% (16% for highly compensated
employees) of base plus quarterly pay for their total before-tax and after-tax
contributions.

Employees may direct the investment of their contributions and the company
match among a Lubrizol share fund and ten other funds with a range of investment
characteristics.

Employees vest in profit sharing and matching contributions at a rate of
20% per year of service. The plan allows distribution of an employee's vested
account balance after retirement, death or other termination of employment.

DEFERRED COMPENSATION PLANS

We have a deferred compensation plan for executive officers. Under this
plan, executive officers may defer all or any portion of their total annual pay
and have these amounts credited to various cash investment accounts and/or a
share unit account. The investment returns of the cash investment accounts equal
the performance of the investment portfolios designated by the Organization and
Compensation Committee. The number of share units credited to the share unit
account is based on the price of Lubrizol shares on the day the share units are
credited to the account and includes additional share units credited for
quarterly dividends paid on Lubrizol shares. At the end of the deferral period,
the deferrals and earnings are distributed to the participant. Cash is
distributed from the cash account and Lubrizol shares are issued equal to the
number of share units in the participant's share unit account.

In addition, we have another deferred compensation plan for some executive
officers. Under this plan, participants may defer any amount of their variable
pay under the performance pay plan. Deferred amounts are converted into share
units based on the current market price of Lubrizol's shares. Lubrizol matches
25% of the amount deferred. Additional share units are credited for quarterly
dividends paid on Lubrizol shares. At the end of the deferral period, which is
at least three years, Lubrizol shares are issued equal to the number of share
units in the participant's account. For units attributable to match that is
credited after January 1, 2004, the distribution will be made in cash.

SUPPLEMENTAL RETIREMENT PLAN

We have a supplemental retirement plan for Donald W. Bogus under which 500
share units are credited to an account on each April 1 until his retirement from
Lubrizol. The account is also credited with additional share units for quarterly
dividends paid on Lubrizol shares. Upon his retirement, he may elect to receive
the balance of his account in cash or common shares. For units credited after
January 1, 2004, the distribution will be made in cash.

EXECUTIVE DEATH BENEFIT PROGRAM

The Organization and Compensation Committee selects executive officers to
participate in an executive death benefit program. This program provides a
benefit to the executive officer's designated beneficiary following the
executive officer's death. The death benefit is 250% of the participant's base
salary plus quarterly pay for a designated year, reducing to 150% at age 70 and
100% at age 75.

EXECUTIVE AGREEMENTS

We have employment termination agreements with senior executives, including
Messrs. Bares, Hambrick, Hill, Cooley, Bogus and Kirk. Each termination
agreement provides that, in the event of a change in control of Lubrizol, the
executive will be employed by Lubrizol for up to three years at responsibility,
salary and benefit levels equal to those immediately preceding the change in
control. If the executive's employment is terminated during those three years
for reasons other than death, permanent disability, reaching age 65 or for
cause, or if the executive terminates employment in specified circumstances, the
benefits provided to the executive are:

(1) a lump sum payment equal to three times the salary and other forms of
cash compensation in effect at the time of termination, and

(2) continued employee benefit coverage for the remainder of the three
years.

The termination agreements also provide that the executive will receive an
amount which will cover any excise taxes that apply.

Each executive has agreed, if the executive accepts any benefits under the
termination agreement, not to compete with Lubrizol for one year after
termination of employment after a change in control.

Assuming a change in control were to occur and all of the executive
officers who have termination agreements were terminated as of January 1, 2004,
the estimated amount of payments which we would have to make under the
termination agreements (including amounts to cover excise taxes) is $36 million.

In addition to the employment termination agreements, we have employment
retention agreements with Messrs. Cooley, Kirk and Bogus and Di Biase (Vice
President). Under the agreement for Dr. Di Biase, 5,000 shares will be granted
if he remains employed until January 1, 2008. Under the agreements for Messrs.
Cooley, Kirk and Bogus, 15,000 shares will be granted to each executive if he
remains employed until January 1, 2008. In addition, the agreements for Messrs.
Kirk and Bogus provide for participation in the executive death benefit program
and the special officers' supplemental defined benefit plan at the later of
January 1, 2008 or age 60, provided that the executive is still employed by
Lubrizol on that date.

We agreed to pay the relocation expenses for Joe E. Hodge, Vice President,
to move from Ohio back to his home state of Texas, at the time of his assignment
to Ohio in 1993. His relocation back to Texas occurred in December 2003. The
expenses, including tax gross-ups, were approximately $107,000 and were paid
using the provisions of Lubrizol's relocation policy as a guide.

EMPLOYEE SEVERANCE COMPENSATION PLAN

We also have a severance compensation plan that provides for a severance
payment to employees if, within 15 months after a change in control of Lubrizol,
their employment is terminated for any reason other than death, permanent
disability, voluntary retirement or for cause. Executives who receive payments
under the executive termination agreements described above will not receive
severance payments under the severance compensation plan.

For an employee with five or more years of service with Lubrizol, the
benefit under the severance compensation plan is a lump sum payment equal to the
total cash compensation received by the employee in the preceding 12-month
period. Employees with less than five years but more than six months of service
would receive a lesser amount proportionate to their length of service.

--------------------------------------------------------------------------------

SECTION 16(a) BENEFICIAL OWNERSHIP
REPORTING COMPLIANCE
--------------------------------------------------------------------------------

Section 16(a) of the Securities Exchange Act of 1934 requires our officers
and directors, and some persons who own more than 10% of our shares, to file
reports of share ownership and change in ownership with the Securities and
Exchange Commission, with a copy to us. We are not aware of any shareholder who
owns more than 10% of our shares and is required to file these reports.

Based solely on a review of the copies of the forms furnished to us during
or for 2003 and written statements from officers and directors, we believe that
all officers and directors filed on time all reports required during 2003 and
any prior year except that Charlie Cooley, Joe Hodge, Mark Meister, Rosanne
Potter and Joanne Wanstreet each had one late filing reporting one transaction,
and Don Bogus, Steve Di Biase and Steve Kirk each had two late filings,
reporting two transactions.

--------------------------------------------------------------------------------

APPOINTMENT OF AUDITORS
--------------------------------------------------------------------------------

The Audit Committee appointed Deloitte & Touche LLP, independent auditors,
to audit the financial statements of Lubrizol for the year 2004. The Board of
Directors recommends that you confirm this appointment.

During 2003, Lubrizol engaged Deloitte & Touche to render a variety of
services, including the audit of Lubrizol's financial statements. A Deloitte &
Touche representative will attend the annual meeting, will have the opportunity
to make a statement and will be available to answer questions.

INDEPENDENT ACCOUNTANT FEES

The following table summarizes the aggregate fees billed by Deloitte &
Touche LLP:

2003 2002
---------- ----------

Audit Fees(1)............................................... $1,051,903 $1,065,015
Audit-Related Fees(2)....................................... 155,075 334,970
Tax Fees(3)................................................. 297,222 372,391
All Other Fees(4)........................................... 38,799 26,002
---------- ----------
Total..................................................... $1,542,999 $1,798,378

---------------
(1) Fees for audit services billed in 2003 and 2002 consisted of:

- Audit of the annual financial statements

- Reviews of the quarterly financial statements

(2) Fees for audit-related services billed in 2003 and 2002 consisted of:

- Employee benefit plan audits

- Opening and closing balance sheet audits/reviews of acquisitions

- Agreed-upon procedures engagements

- Financial accounting and reporting consultations

- Due diligence associated with mergers/acquisitions

- Sarbanes-Oxley Act, Section 404 advisory services

(3) Fees for tax services billed in 2003 and 2002 consisted of the following
compliance and tax planning and advice:

- Federal and state income tax planning advice

- Assistance with tax return compliance in certain foreign jurisdictions

- Assistance with foreign tax audits

- Tax planning advice in certain foreign jurisdictions

(4) Fees for all other services billed in 2003 and 2002 consisted of the
following permitted non-audit services:

- Tax software license fees

- Human capital advisory services

In considering the nature of the services provided by Deloitte & Touche,
the Audit Committee determined that these services are compatible with the
provision of independent audit services. The Audit Committee discussed these
services with Deloitte & Touche and management to determine that the services
are permitted under the rules and regulations concerning auditor independence
promulgated by the Securities and Exchange Commission to implement the
Sarbanes-Oxley Act of 2002.

All audit and non-audit services performed by Deloitte and Touche must be
pre-approved by the Audit Committee. The committee adopted a pre-approval
policy, which provides that between committee meetings, the Chair of the Audit
Committee, after considering the effect of these services on the auditor's
independence, may pre-approve audit and non-audit services up to $25,000 for
each engagement, not to exceed $75,000 in the aggregate. All services approved
by the Chair are reported to the Audit Committee at its next meeting. All of the
services provided by Deloitte and Touche during 2003 were pre-approved by the
Audit Committee or pursuant to the pre-approval policy.
--------------------------------------------------------------------------------

SHAREHOLDER PROPOSALS FOR THE 2005 ANNUAL MEETING
--------------------------------------------------------------------------------

Any shareholder who wants to present a proposal at the 2005 Annual Meeting
of Shareholders and have it included in our proxy materials must send us the
proposal no later than November 18, 2004. Shareholder proposals submitted after
that date but on or before February 24, 2005, may be presented at the annual
meeting but will not be included in the proxy materials. If a shareholder
proposal is received after February 24, 2005, the persons named on the proxy
card may vote in their discretion regarding the proposal all of the shares for
which we have received proxies for the annual meeting.

THE LUBRIZOL CORPORATION

L. M. Reynolds
Secretary

March 17, 2004

APPENDIX A

THE LUBRIZOL CORPORATION

AUDIT COMMITTEE CHARTER

ORGANIZATION

There shall be a standing committee of the Board of Directors to be known
as the Audit Committee, composed solely of at least three independent directors,
each of whom is or shall become financially literate within a reasonable period
of time after appointment, at least one of whom shall have accounting or related
financial management expertise, and at least one whom is a financial expert, as
that term is defined by the Securities and Exchange Commission. Members are
considered independent if they have no relationship to the corporation that may
interfere with the exercise of their independence and judgment in carrying out
their responsibilities, as set forth in the New York Stock Exchange rules on
audit committees. The Board of Directors annually shall determine whether in its
business judgment a member: is independent; is financially literate; has
accounting or related financial management expertise; is a financial expert in
accordance with Securities and Exchange Commission regulations. The authority
and responsibilities of the Audit Committee are defined in this Charter. The
responsibilities of a member of the Audit Committee are in addition to those set
out for a member of the Board.

AUTHORITY

Primary responsibility for the Company's management processes and systems,
internal control structure and financial reporting is vested in senior operating
management as overseen by the Board. The Audit Committee is established to
assist Board oversight of: (1) the Company's financial statements; (2) the
Company's compliance with legal and regulatory requirements; (3) the independent
auditor's qualifications and independence; and (4) the performance of the
Company's internal audit function and independent auditors. The Audit Committee,
on behalf of the Board, represents the interests of the Company's shareholders,
potential shareholders, and investment community, and as such, is the principal
client of the independent and internal auditors. The Audit Committee hires the
independent auditor, which is ultimately accountable to the Board of Directors
and the Audit Committee.

REPORTING AND COMMUNICATIONS

The Audit Committee Chairperson shall report the Audit Committee's
activities to the full Board on a regular and timely basis. The Audit Committee
shall have candid communications with the independent and internal auditors, and
financial management, and have appropriate access to Company personnel and
documents. The Audit Committee will be given the resources necessary to
discharge its responsibilities.

MEETINGS

The Audit Committee will meet as required, and at least three times each
year. The Audit Committee shall have private sessions of Audit Committee members
and meetings with the Chief Executive Officer and other senior management of the
Company, the Chief Ethics Officer, and the independent and internal auditors, on
a regular basis, and with legal counsel as needed.

RESPONSIBILITIES

Overall, the Audit Committee shall be responsible for:

- Monitoring financial reporting, audit processes and risk control-related
matters.

- Influencing the overall corporate commitment to quality financial
reporting, sound business risk controls, and ethical and legal behavior.

A-1

More specifically, the Audit Committee's oversight activities include but
are not limited to the following:

1. Reviewing and reassessing the adequacy of this Charter annually, and
submitting the Charter to the Board for approval annually.

2. Appointing, evaluating and terminating the independent auditing firm to
audit the Company's consolidated financial statements for the year.

3. Reviewing the annual plan for services to be provided by the independent
auditor, which includes, but is not limited to:

- Reviewing the annual audit scope, including, staffing, timing and the
estimated and actual fees.

- Reviewing the scope of any non-audit services planned or performed by
the independent auditors, as well as related fees, and considering the
possible effect that these services could have on the independence of
such auditors. Note: The independent auditors are prohibited from
providing the services listed in Rule 2-01 of Regulation S-X.

- Obtaining from the independent auditor a formal written statement
delineating all relationships between the auditor and the Company as
required by the Independence Standards Board on an annual basis.

4. Pre-approving all audit and non-audit services to be provided by the
independent auditor.

5. Obtaining, at least annually, and reviewing a report by the independent
auditor describing:

- Its internal quality control procedures.

- Any material issues raised by the most recent internal quality control
review or peer review of the firm, or by any inquiry or investigation by
governmental or professional authorities within the preceding five
years, respecting one or more independent audits carried out by the firm
and any steps taken to deal with such issues.

- All relationships between the independent auditor and the Company (to
assess auditor independence).

6. Reviewing the adequacy and effectiveness of the internal audit function
of the Company, including concurring on the appointment, replacement,
reassignment, or dismissal of the senior internal auditor.

7. Reviewing the impact of adopted or proposed significant changes in
accounting principles and reporting requirements.

8. Reviewing annually the actuarial assumptions of the Company and its
major domestic and subsidiary pension plans.

9. Prior to the release of quarterly and annual earnings, reviewing with
financial management and the independent auditor: (1) matters that affect the
Company's consolidated financial statements; (2) the results of the independent
auditor's interim reviews and annual audit and report, including discussions
regarding qualitative judgments about the appropriateness, not just the
acceptability, of the Company's accounting principles; (3) all critical
accounting policies and practices to be used; (4) all alternative treatments of
financial information within generally accepted accounting principals related to
material items that have been discussed with management, the ramifications of
the use of such alternative disclosures and treatments, and the treatment
preferred by the independent auditor; and (5) other material written
communications between the independent auditor and management, such as any
management letter or schedule of unadjusted differences. Discussions held prior
to the release of quarterly and annual earnings may be conducted by the
Chairperson on behalf of the Audit Committee, in which case the Chairperson
shall advise the Audit Committee of the results of such discussions at the next
regularly scheduled meeting.

A-2

10. Prior to the issuance of the annual report to shareholders:

- Reviewing with the independent auditor any audit problems or
difficulties and management's response.

- Reviewing Management's Discussion and Analysis of Financial Condition
and Results of Operations along with the financial statements and
Independent Auditor's Report.

- Discussing any matters that the independent auditor communicates to the
Audit Committee, including matters required by generally accepted
auditing standards, laws or regulations, or otherwise required to be
communicated.

- Issuing a report for inclusion in the Company's annual proxy statement
in accordance with applicable Securities and Exchange Commission
regulations.

11. Discussing earnings press releases as well as financial information and
earnings guidance provided to analysts and rating agencies.

12. Overseeing the internal control structure established by management,
including management's annual assessment of the effectiveness of the internal
control structure and procedures for financial reporting.

13. Discussing policies with respect to risk assessment and risk
management.

14. Providing oversight of the activities of the Chief Ethics Officer and
annually reviewing management procedures for monitoring compliance with the
Company's Policy on Ethical and Legal Conduct.

15. Obtaining advice and assistance, as appropriate, from outside legal,
accounting or other advisers.

16. Meeting separately, periodically, with management, the independent
auditor and internal auditors.

17. Reviewing and assessing with management the programs and policies of
the Company designed to ensure compliance with applicable laws and regulations
and monitoring the results of the efforts.

18. Setting clear hiring policies for employees or former employees of the
independent auditor.

19. Reporting regularly to the Board.

20. Performing annual self-assessments and assessments of management, and
the independent and internal auditors' performance against criteria and
expectations.

21. Receiving, retaining and addressing complaints received by the Company
regarding accounting, internal accounting controls or auditing matters

22. Performing other oversight functions as it deems necessary, or as
requested by the Board, such as:

- Periodically meeting with management and the independent and internal
auditors to agree on mutual expectations, a detailed plan of Audit
Committee activities and the nature, extent and timing of Audit
Committee information needs.

A-3

ANNUAL MEETING OF SHAREHOLDERS OF
THE LUBRIZOL CORPORATION

April 26, 2004

-------------------------------------
PROXY VOTING INSTRUCTIONS
-------------------------------------

MAIL - Date, sign and mail your proxy card in the
envelope provided as soon as possible.

- OR -
-------------------------------

TELEPHONE - Call toll-free 1-800-PROXIES from COMPANY NUMBER
any touch-tone telephone and follow the instructions.
Have your proxy card available when you call. -------------------------------

ACCOUNT NUMBER

-------------------------------
- OR -
INTERNET - Access "www.voteproxy.com" and
follow the on-screen instructions. Have your proxy
card available when you access the web page.

* PLEASE detach along perforated line and mail in the envelope provided IF you are not voting via telephone or the Internet. *
-------------------------------------------------------------------------------------------------------------------------------
[ ]

_______________________________________________________________________________________________________________________________

PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE [X]
_______________________________________________________________________________________________________________________________

FOR AGAINST ABSTAIN
1. Election of Directors: 2. Confirmation of appointment of Deloitte & Touche LLP as [ ] [ ] [ ]
Independent Auditors.
NOMINEES:
[ ] FOR ALL NOMINEES - James L. Hambrick The Board of Directors recommends a vote FOR the above
- Gordon D. Harnett proposal.
- Victoria F. Haynes
[ ] WITHHOLD AUTHORITY - William P. Madar TO INCLUDE ANY COMMENTS, USE THE COMMENTS BOX ON THE REVERSE
FOR ALL NOMINEES SIDE HEREOF.

[ ] FOR ALL EXCEPT (Comments will be collected by the Inspector of Elections and
(See instructions below) forwarded to LUBRIZOL management)

INSTRUCTION: To withhold authority to vote for any individual nominee(s), mark
"FOR ALL EXCEPT" and fill in the circle next to each nominee you
wish to withhold, as shown here: _

________________________________________________________________________________

To change the address on your account, please check the box at right and
indicate your new address in the address space above. Please note that [ ]
changes to the registered name(s) on the account may not be submitted via
this method.
________________________________________________________________________________

Signature of Shareholder _____________________ Date: _________ Signature of Shareholder _____________________ Date: _________

Note: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign.
When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a
corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a
partnership, please sign in partnership name by authorized person.

Electronic Distribution

IF you would like to receive future The Lubrizol Corporation proxy
statements and annual reports electronically, please visit
http://www.amstock.com. Click on Shareholder Account Access to enroll.
After logging in, select Receive Company Mailings via Email.

Annual Meeting of Shareholders

The Lubrizol Corporation's Annual Meeting of Shareholders will be held at
10:00 a.m. on April 26, 2004, at the Radisson Hotel & Conference Center -
Eastlake, 35000 Curtis Boulevard, Eastlake, Ohio. Please see your proxy
statement for instructions should you wish to attend the meeting.

PROXY
THE LUBRIZOL CORPORATION
Proxy Solicited on Behalf of the Board of Directors

The undersigned shareholder of The Lubrizol Corporation hereby appoints
W. G. Bares, C. P. Cooley and L. M. Reynolds, and each of them, as agents, with
full power of substitution, to vote the shares of the undersigned at the 2004
Annual Meeting of Shareholders of The Lubrizol Corporation to be held on April
26, 2004, and at any adjournments thereof, as indicated on the reverse side of
this proxy card.

Please specify your choices by marking the appropriate boxes on the reverse
side. If no specification is made, authority is granted to cast the vote of the
undersigned FOR ELECTION of the nominees and FOR Item 2. The agents named above
cannot vote your shares unless you sign and return this proxy card or choose
alternative voting options as indicated on the reverse side of this proxy card.

(Continued and to be signed on the reverse side)

-------------------------------------------------------------------------------
COMMENTS:

-------------------------------------------------------------------------------